- Home
- ONON vs AXSM Comparison
ONON vs AXSM Comparison
Compare ONON & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONON | AXSM |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 12.0B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ONON | AXSM |
|---|---|---|
| Price | $35.89 | $240.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 17 |
| Target Price | $60.15 | ★ $211.12 |
| AVG Volume (30 Days) | ★ 3.8M | 845.0K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.58 | $57.24 |
| Revenue Next Year | $19.98 | $55.88 |
| P/E Ratio | $56.05 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.41 | $96.09 |
| 52 Week High | $52.41 | $260.19 |
Technical Indicators
Market Signals| Indicator | ONON | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 51.12 |
| Support Level | $34.94 | $236.44 |
| Resistance Level | $38.56 | $256.40 |
| Average True Range (ATR) | 1.44 | 9.57 |
| MACD | -0.19 | -0.26 |
| Stochastic Oscillator | 19.05 | 56.90 |
Price Performance
Historical ComparisonAbout ONON On Holding AG
Founded in Switzerland in 2010, sportswear firm On Holding generates 93% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.